Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

被引：2
|
作者：
Agostinetto, Elisa [1 ,2 ,3 ,7 ]
Ceppi, Marcello [4 ]
Bruzzone, Marco [4 ]
Lambertini, Matteo [5 ,6 ]
de Azambuja, Evandro [1 ,2 ]
机构：
[1] Inst Jules Bordet, Acad Trials Promoting Team, Blvd Waterloo 121, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles ULB, Brussels, Belgium
[3] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy
[4] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[5] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[6] IRCCS Osped Policlin San Martino, Dept Med Oncol, UO Clin Oncol Med, Genoa, Italy
[7] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Pieve Emanuele Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 155卷
关键词：
D O I：
10.1016/j.ejca.2021.06.042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：303 / 306
页数：4
相关论文
共 50 条
  • [41] Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
    Song Li
    Qian Xu
    Xin Dai
    Xue Zhang
    Miao Huang
    Kai Huang
    Duanbo Shi
    Jian Wang
    Lian Liu
    Annals of Surgical Oncology, 2023, 30 : 3594 - 3602
  • [42] Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Zhao, Mei
    Chen, Shanwen
    Li, Conggui
    Du, Yingying
    Li, Ping
    CANCERS, 2023, 15 (03)
  • [43] Safety of Combination Immune Checkpoint Inhibitors Compared to Monotherapy; A Systematic Review and Meta-Analysis
    Abdelhafeez, Ahmed A. M.
    Shohdy, Kyrillus S.
    Ibrahim, Wael
    CANCER INVESTIGATION, 2020, 38 (03) : 150 - 157
  • [44] Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
    Zeng, Tianni
    Fang, Xiaojie
    Lu, Jinhua
    Zhong, Yazhen
    Lin, Xianlei
    Lin, Zechen
    Wang, Nan
    Jiang, Jing
    Lin, Shengyou
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (01) : 251 - 258
  • [45] Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
    Tianni Zeng
    Xiaojie Fang
    Jinhua Lu
    Yazhen Zhong
    Xianlei Lin
    Zechen Lin
    Nan Wang
    Jing Jiang
    Shengyou Lin
    International Journal of Colorectal Disease, 2022, 37 : 251 - 258
  • [46] The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
    Ababneh, Obada
    Ghazou, Alina
    Alawajneh, Mohmmad
    Alhaj Mohammad, Saleh
    Bani-Hani, Abdullah
    Alrabadi, Nasr
    Shreenivas, Aditya
    CANCERS, 2024, 16 (05)
  • [47] The Effect of Sex on the Therapeutic Efficiency of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
    Zhong, Xingyu
    Sun, Jianxuan
    Zeng, Na
    Xiong, Yifan
    An, Ye
    Wang, Shaogang
    Xia, Qidong
    CANCERS, 2024, 16 (02)
  • [48] Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Kim, Jong Yeob
    Kronbichler, Andreas
    Eisenhut, Michael
    Hong, Sung Hwi
    van der Vliet, Hans J.
    Kang, Jeonghyun
    Shin, Jae Il
    Gamerith, Gabriele
    CANCERS, 2019, 11 (11)
  • [49] Pancreatitis in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
    Mako Koseki
    Yoshito Nishimura
    Evelyn Elias
    Jonathan Estaris
    Fnu Chesta
    Kensuke Takaoka
    Theresa Shao
    Nobuyuki Horita
    Yu Fujiwara
    Targeted Oncology, 2024, 19 (6) : 867 - 877
  • [50] Patients with sarcomatoid renal cell carcinoma-re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors
    Iacovelli, Roberto
    Ciccarese, Chiara
    Bria, Emilio
    Bracarda, Sergio
    Porta, Camillo
    Procopio, Giuseppe
    Tortora, Giampaolo
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 195 - 203
12345